BIO-key Q1 FY26 net loss narrows to $165,036; revenue rises 34% to $2.15 million

BIO-key International, Inc.

BIO-key International, Inc.

BKYI

0.00

  • BIO-key posted Q1 2026 revenue of USD 2.15 million, up 34% from a year earlier, while its net loss narrowed to USD 165,036.
  • Gross margin held at 82%, as operating expenses dipped 4% to USD 1.89 million.
  • Cash and cash equivalents ended the quarter at USD 2.25 million, while accounts receivable rose to USD 1.57 million.
  • Recent business included a USD 1.04 million one-year biometric identity license renewal with a foreign bank, about USD 450,000 in follow-on orders supporting a foreign defense ministry, and a multi-year agreement with Mozambique’s national payments network operator SIMO.
  • For Q2 2026, revenue is expected to rise 65% to about USD 2.8 million, with management targeting profitability in the first half of 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BIO-key International Inc. published the original content used to generate this news brief on May 18, 2026, and is solely responsible for the information contained therein.